LGT209

· Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LGT209, covering 2013-12-10 to 2013-12-10. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability, PK and PD of LGT209 in Healthy Volunteers and Patients With Hypercholesterolemia [Phase 1]